AERWINS Technologies Inc.: Nasdaq/NYSE listing notice — Nasdaq delists AERWINS for bid-price noncompliance; company plans appeal hearing

AERWINS Technologies Inc.

Received Nasdaq delisting determination on Oct 18, 2023 for failing to meet $1.00 minimum bid price for 180-day cure period.
Delisting scheduled for Oct 27, 2023; company has until Oct 25 to request a hearing before a Hearings Panel.
Company intends to timely request a hearing to stay delisting and present a plan to regain compliance.
Also out of compliance with Nasdaq market value of listed securities (Rule 5450(b)(2)(A)) and minimum MVPHS (Rule 5450(b)(2)(C)).
No assurance that the Panel will grant continued listing or that company will ultimately regain compliance.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

AERWINS Technologies Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5450(a)(1)

Exact text from the filing

October 18, 2023, AERWINS Technologies Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined to delist the Company’s common stock and warrants from The Nasdaq Global Market due to the Company not having regained compliance with Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”) during the 180-calendar-day period (the “Compliance Period”) following the deficiency letter the Company received from the Staff on April 20, 2023, regarding

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001493152-23-037935

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.